Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Physiomics ( (GB:PYC) ) just unveiled an update.
Physiomics plc has announced the recruitment of Mr. Jesse Thissen as the new Head of Biometrics, alongside securing its first two Biometrics contracts with a UK-based biopharmaceutical company. These contracts, valued at £111,000, will involve providing Biostatistical Consulting and Statistical Programming services for the client’s clinical programs. The addition of Mr. Thissen, an experienced biostatistician, is expected to drive growth in Physiomics’ new Biometrics service-line, complementing its existing modelling and simulation services. This strategic move is anticipated to enhance the company’s market positioning by offering a broader integrated solution, enabling rapid scaling and meeting growth aspirations.
Spark’s Take on GB:PYC Stock
According to Spark, TipRanks’ AI Analyst, GB:PYC is a Underperform.
Physiomics’ stock score is primarily impacted by significant financial instability, including declining revenues and negative profit margins. Technical indicators reinforce a bearish outlook. While recent corporate events suggest potential growth pathways, current valuation issues and financial challenges remain significant obstacles.
To see Spark’s full report on GB:PYC stock, click here.
More about Physiomics
Physiomics plc is a leading company in the fields of mathematical modelling, data science, and biostatistics, supporting the development of new therapeutics and personalized medicine solutions. The company utilizes its expertise in Modelling & Simulation, Biostatistics, Data Science, and Bioinformatics to aid biotech and pharma companies in optimizing their drug development processes. Physiomics employs cutting-edge computational tools, bespoke models, and its proprietary Virtual Tumour technology to inform the development of commercial projects for clients such as Merck KGaA, Astellas, and Bicycle Therapeutics.
Average Trading Volume: 8,722,642
Technical Sentiment Signal: Sell
Current Market Cap: £1.39M
See more data about PYC stock on TipRanks’ Stock Analysis page.

